drugset
drugset / Trial / NCT06408948

A Study to Evaluate the Mass Balance of [14C]SHR7280 in Healthy Adult Volunteers

NCT06408948 ↗

Phase 1 Completed 6 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelOther

Summary

Evaluate the Mass Balance of \[14C\]SHR7280 in Healthy Adult Volunteers.

Timeline

Start
2024-06-07
Primary completion
2024-07-06
Completion
2024-07-06

Drugs

EvaluationDrugModalityDoseRoute
Subject SHR7280 Small molecule — Oral

Indications

No indication recorded.